Long-term treatment with aripiprazole on the waking and postprandial urges to smoke in Chinese heavy smokers

Journal of Clinical Psychopharmacology
Yu LiuLin Lu

Abstract

The central dopaminergic system plays a critical role in the reinforcing effects of nicotine, which are key determinants in the urge to smoke. Previous study has demonstrated that immediate administration of 10-mg aripiprazole significantly decreased various subjective responses to smoking. The present study investigated whether 2-week treatment with 10-mg aripiprazole could attenuate waking and postprandial urges to smoke in Chinese male and female heavy smokers. A randomized and placebo-controlled pilot clinical study was conducted to assess the effect of aripiprazole on various responses to smoking. The primary outcomes were subject's ratings on questionnaires of smoking urge, withdrawal syndromes, and cigarette evaluation. All participants were administered either placebo or 10-mg aripiprazole for 2 weeks. Throughout the experiment, participants were required to self-report (1) smoking urge and nicotine withdrawal symptoms before their first cigarette after awakening and after lunch and (2) subjective responses to the first cigarette smoked of the day and after lunch. Aripiprazole was associated with significantly decreased waking and postprandial urges to smoke. Aripiprazole failed to produce a significant effect on overal...Continue Reading

References

Oct 20, 1976·Psychopharmacology·S M Shiffman, M E Jarvik
Jun 1, 1992·Drug and Alcohol Dependence·R W Pickens, C E Johanson
Nov 1, 1991·British Journal of Addiction·S T Tiffany, D J Drobes
Sep 1, 1991·British Journal of Addiction·T F HeathertonK O Fagerström
Jan 1, 1991·Archives of General Psychiatry·J R HughesJ W Fenwick
Jul 1, 1989·Pharmacology, Biochemistry, and Behavior·B L LeeN L Benowitz
Jan 1, 1989·Addictive Behaviors·M E JarvikD Oisboid
Mar 1, 1986·Archives of General Psychiatry·J R Hughes, D Hatsukami
Oct 1, 1994·Trends in Pharmacological Sciences·L Pulvirenti, G F Koob
Dec 6, 1997·Nature·V I PidoplichkoJ A Dani
Jan 19, 2000·Trends in Pharmacological Sciences·A R Childress, C P O'Brien
Apr 20, 2000·European Journal of Pharmacology·G Di Chiara
Jul 19, 2000·Pharmacology, Biochemistry, and Behavior·M E JarvikN L Benowitz
Nov 10, 2000·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·K A PerkinsA R Caggiula
Dec 13, 2000·Pharmacology, Biochemistry, and Behavior·J E RoseM Johnson
Mar 22, 2001·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·L S CoxA G Christen
Mar 22, 2001·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·R NiauraD B Abrams
Mar 27, 2001·Pharmacology, Biochemistry, and Behavior·J E RoseE C Westman
Feb 14, 2002·Pharmacology, Biochemistry, and Behavior·P J Kenny, A Markou
Jun 18, 2002·The Journal of Pharmacology and Experimental Therapeutics·Kevin D BurrisPerry B Molinoff
Mar 26, 2003·Journal of Abnormal Psychology·Thomas M PiaseckiTimothy B Baker
Jan 30, 2004·Journal of Clinical Pharmacology·Suresh MallikaarjunSteven L Bramer
Aug 11, 2004·Journal of Consulting and Clinical Psychology·Antonio Cepeda-BenitoStephen Erath
Sep 29, 2004·Addictive Behaviors·John R HughesMark A MacLaughlin
Dec 17, 2004·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Timothy J Turner
Feb 11, 2005·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Marcus MunafòSean David
May 19, 2005·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Mustafa WarsiFrederick Petty
Jun 29, 2005·Journal of Psychopharmacology·R I Ohlsen, L S Pilowsky
Jul 1, 2005·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Joshua A LileCraig R Rush
Jul 14, 2005·Journal of Clinical Psychopharmacology·Thomas P BeresfordHenry F Beresford
Oct 18, 2005·Addictive Behaviors·Benjamin A TollSherry A McKee
Dec 15, 2005·Clinical Psychology Review·Thomas M Piasecki
Feb 28, 2006·Addiction·Jean-François Etter, John R Hughes
Mar 17, 2006·Drug and Alcohol Dependence·William W StoopsCraig R Rush
May 11, 2006·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·Kimmo IngmanEsa R Korpi
Jun 30, 2006·Biological Psychiatry·Matthew W FeltensteinRonald E See
Jul 25, 2006·Primary Care Companion to the Journal of Clinical Psychiatry·Sriram Ramaswamy, Subhash C Bhatia
Nov 23, 2006·Experimental and Clinical Psychopharmacology·William W Stoops
Jan 5, 2007·The American Journal of Psychiatry·Jari TiihonenEsa Meririnne
Feb 27, 2007·Drug and Alcohol Dependence·Benjamin A TollSuchitra Krishnan-Sarin
Mar 1, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Sunmee WeeGeorge F Koob
Jun 15, 2007·Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors·Benjamin A TollSuchitra Krishnan-Sarin
Jul 7, 2007·The American Journal of Drug and Alcohol Abuse·Giovanni MartinottiLuigi Janiri
Sep 18, 2007·Journal of Clinical Psychopharmacology·Luigi JaniriMarco Di Nicola

❮ Previous
Next ❯

Citations

Feb 7, 2017·Journal of Dual Diagnosis·Heidi J WehringDeanna L Kelly
Nov 28, 2020·Current Treatment Options in Oncology·Mellar P Davis, Gareth J Sanger

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.